SG/PUT/NOVO-NORDISK B/700/0.2/21.06.24 Stock

Warrant

DE000SW2BDV5

Market Closed - Deutsche Boerse AG 15:45:08 2024-05-31 EDT
0.001 EUR -.--% Intraday chart for SG/PUT/NOVO-NORDISK B/700/0.2/21.06.24
3 months-99.77%
6 months-99.95%
Date Price Change
24-05-31 0.001 -.--%
24-05-30 0.001 -.--%
24-05-29 0.001 -.--%
24-05-28 0.001 -.--%
24-05-27 0.001 -.--%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 03:45 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SW2BDV
ISINDE000SW2BDV5
Date issued 2023-08-16
Strike 700 kr
Maturity 2024-06-21 (19 Days)
Parity 5 : 1
Emission price 2.9
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.98
Lowest since issue 0.001
Delta0x
Omega 0.000000
Premium0x
Gearing801.31x
Moneyness 0.7549
Difference Strike -227.3 kr
Difference Strike %-32.47%
Spread 0.06
Spread %98.36%
Intrinsic value 0.000000

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
927.3 DKK
Average target price
917.2 DKK
Spread / Average Target
-1.09%
Consensus